Next Generation Sequencing Claims in Precision Medicine: Questions a Formulary Committee Should Ask
The enthusiasm with which precision medicine has been embraced over the past 15 years has obscured the fact that the evidence base for biomarker-driven assessments, in particular for next generation sequencing (NGS), is limited. This applies both to the comparative performance of the various assessm...
Saved in:
| Main Author: | |
|---|---|
| Format: | Book |
| Published: |
University of Minnesota Libraries Publishing,
2016-11-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|